benphothiamine has been researched along with Cochlear Hearing Loss in 5 studies
benfotiamine : A thioester that is a synthetic analogue of thiamine obtained by acylative cleavage of the thiazole ring and O-phospohorylation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalwadi, P | 1 |
Joshi, AS | 1 |
Thakur, DS | 1 |
Bhagwat, NM | 1 |
Kornienko, AM | 1 |
Kornienko, RA | 1 |
Antoniv, VF | 1 |
Efimochkina, KV | 1 |
Antoniv, TV | 1 |
Popadiuk, VI | 1 |
Kakupshev, AU | 1 |
Atanesian, AG | 1 |
Kosiakov, SIa | 1 |
Manuĭlov, OE | 1 |
Bezzubenko, LA | 1 |
1 trial available for benphothiamine and Cochlear Hearing Loss
Article | Year |
---|---|
[Milgamma in the treatment of chronic neurosensory hypoacusis].
Topics: Adjuvants, Immunologic; Adult; Aged; Chronic Disease; Hearing Loss, Sensorineural; Humans; Middle Ag | 2004 |
4 other studies available for benphothiamine and Cochlear Hearing Loss
Article | Year |
---|---|
Neonatal diabetes mellitus: remission induced by novel therapy.
Topics: Administration, Oral; Anemia, Megaloblastic; Diabetes Mellitus; Diabetic Ketoacidosis; Female; Frame | 2019 |
[Sensorineural hearing loss: New prospects for therapy].
Topics: Adjuvants, Immunologic; Administration, Oral; Aged; Audiometry; Disease Progression; Dose-Response R | 2011 |
[The importance of the pharmaceutical form and the routes of administration of B-group vitamins for the efficacious treatment of neurosensorial hearing loss].
Topics: Adult; Biopharmaceutics; Cochlear Nerve; Hearing Loss, Sensorineural; Humans; Male; Nerve Regenerati | 2012 |
[The role of neurotropic therapy in the treatment of acute sensorineural impairment of hearing following a viral infection].
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Biological Availability; Cochlear Nerve; Drug Monitori | 2012 |